WHITEPAPER: IRT systems can be a double-edged sword. Set up properly, it can make your clinical supply strategy a breeze to execute. Set up improperly, it can apply additional pressure and stress to a sponsor’s resupply execution
WHITE PAPER: When pharmaceutical and biopharmaceutical companies engage in new product development, there is a historical tendency to focus on the immediate needs of the clinical phase. As a result, many commercialization-related decisions...
VIDEO: Selecting the right partner to handle your package design can be crucial in successful commercialization. Learn how choosing PCI can be beneficial in streamlining the process, saving you time and money.
AUDIO: 2020 has been a year that has delivered the world many challenges, the equilibrium has shifted and so many things are no longer as they should be. The Pharmaceutical Industry, like many others, has had to adjust to a “New Norm”
WHITEPAPER: When biotech and pharma companies transport investigational medical products (IMPs) internationally, they are often required to pay import
WHITEPAPER: A clinical distribution plan must be solid enough to begin planning activities, and flexible enough to adapt to inevitable changes. A good
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Your bridge between life-changing therapies and patients